PARP1 and colitis: Interestingly, NR treatment did not reduce the activity of PARP1 in DSS colitis, as evidenced by similar levels of pADPr-modified proteins in the intestinal epithelium of DSS+Vehicle versus DSS+NR mice, but NR did unexpectedly reduce pADPr-modified protein levels in Citrobacter-infected mice.